Navigation Links
Coordinated intervention reduced prevalence of drug-resistant CRE in long-term care
Date:6/11/2014

CHICAGO (June 11, 2014) A new study found a nationwide effort to control carbapenem-resistant Enterobacteriaceae (CRE) in Israel reduced CRE cases by improving compliance of infection control standards and using a coordinated intervention focused on long-term care facilities. The study was published in the July issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

"As the global threat of CRE continues to rise, there is a need to better control and understand this bacteria," said Debby Ben-David, MD, a lead author of the study. "Broadening our focus to long-term care facilities made an impact and reduced the prevalence of these infections, demonstrating the need to look beyond acute care hospitals in our infection control interventions."

Since 2006, Israel has faced a nationwide outbreak of CRE throughout its healthcare system. A 2008 cross-sectional prevalence survey conducted in Israeli post-acute care hospitals (PACHs), similar to long term acute care hospitals in the U.S., revealed a high prevalence of CRE carriage in PACH patients. The transfer of colonized patients between acute care hospitals to PACHs and back again fosters the spread of these drug-resistant infections in healthcare institutions. Based on these results, the Israeli National Center for Infection Control (NCIC) initiated a multifaceted intervention in all PACHs, as part of a national program involving all healthcare facilities in the country.

The intervention included: 1) on-site assessments of infection control policies and practices; 2) CRE isolation guidelines targeted to long-term care facilities; 3) mandatory census reporting of CRE carriers sent to NCIC to facilitate monitoring, compliance with guidelines and track infected patient movement into and out of these facilities; and 4) follow-up surveys of CRE carriage in patients to assess the impact of the intervention on carrier prevalence.

The four-year prospective cohort interventional study found a direct correlation between hospitals with a high infection control score from the on-site assessment and a lower risk of newly discovered CRE carriage. Healthcare facilities' compliance with infection control practices, as measured through on-site assessments, increased more than twofold (score of 6.8 to 14.2 out of 16) and the overall carrier prevalence decreased by approximately 25 percent.

The intervention, carried out in the context of a nationwide initiative to contain CRE spread in healthcare facilities, was based on an understanding of the importance of centrally coordinated regional intervention to contain the spread of multidrug-resistant organisms.


'/>"/>

Contact: Tamara Moore
tmoore@gymr.com
202-745-5114
Society for Healthcare Epidemiology of America
Source:Eurekalert

Related medicine news :

1. Study finds coordinated approach improves quality of primary care
2. Cost-saving, coordinated brain care model for older adults attracting nationwide interest
3. Health information laws can be coordinated with health system delivery improvements under EPSDT
4. The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals
5. Coordinated Care Boosts Cardiac Arrest Survival: Study
6. EuroPCR 2014 showcases technological advances in complex cardiovascular interventions
7. Automated link to national intervention guidance helps doctors interpret FRAX results
8. $8 million NIH grant will fund multicenter clinical trial of stroke intervention drug
9. Psychological factors turn young adults away from HIV intervention counseling
10. Society of Interventional Radiology names James Benenati as Dotter Lecturer
11. Interventional radiologists receive honors from SIR Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 26, 2017 , ... Leading CEOs from biotech, pharmaceutical, and ... 31st at The Four Seasons Hotel Boston. , The Boston CEO Conference ... exclusive access to key decision makers who influence deal making and investment. Attendees ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... to announce a new educational seminar to focus on current legislative activity and ... seminar will begin at 1 p.m. Sunday, Sept. 10, and will continue through ...
(Date:5/26/2017)... ... ... Amir Qureshi, MD is the first physician in Arkansas to implant Nuvecta’s ... Nuvectra™ Algovita SCS System has been FDA approved as a treatment option for chronic ... introduce the most powerful SCS system and the only stretchable lead on the market. ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... MN (PRWEB) , ... May 26, 2017 , ... A ... U.S. states with the healthiest seniors are located in the Midwest. With the average ... more and more people are concerned with both the quality and affordability of where ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... , May 26, 2017  Endo International plc (NASDAQ: ... President and CEO, will represent the Company in a fireside ... Conference on Tuesday, June 13, 2017 at 10:40 a.m. PT ... Terranea Resort in Rancho Palos Verdes, CA. ... the event will be available on the Company,s website at ...
(Date:5/26/2017)... BARBARA, Calif. , May 25, 2017  In ... United States , Direct Relief is working with ... overdose-reversing Naloxone available at no cost to community health ... other nonprofit providers nationwide. "Pfizer has ... access to medicines and ensuring patient safety through educational ...
(Date:5/24/2017)... 2017  ivWatch LLC today announced the launch ... to enable seamless integration of ivWatch,s groundbreaking IV ... pumps and other devices. By integrating ivWatch technology ... help health care customers deliver a higher level ... IV therapy. "The ivWatch OEM Board ...
Breaking Medicine Technology: